NCT01609335View on ClinicalTrials.gov

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Alzheimer's Disease

Interventions

DRUG

F-18 FDG

One time intravenous administration of 17 millicurie (mCi) +/- 10%

DRUG

C-11 PiB

One time intravenous administration of 10-20 mCi

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT01609335 - Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults | Biotech Hunter | Biotech Hunter